BeStock  

BioCryst Pharmaceuticals BCRX

US equityMarket cap rank #2750Drug Manufacturers - Specialty & Generic
$8.10 −$0.07 (-0.86%)
Pre-market · Oct 6, 7:30 am ET · After hours $8.10 0.00%
Open$8.17
Prev close$8.17
Day range$7.92 – $8.25
Volume4.71M
Market cap$2.07B
P/E (TTM)–
Dividend yield–

Balance sheet

Line item 2025 ANNUAL 2024 ANNUAL 2023 ANNUAL 2022 ANNUAL 2021 ANNUAL
Gains/Losses Not Affecting Retained Earnings $38,000.00 $921,000.00 $1.34M $26,000.00 $177,000.00
Total Current Liabilities $196.07M $160.38M $149.99M $105.51M $103.72M
Total Liabilities $633.31M $966.35M $972.49M $844.60M $695.14M
Other Non-Current Assets $29.66M $28.34M $80,000.00 $6.81M –
Investments and Advances $61.16M $20.32M $0.00 $18.08M $6.83M
-Gross PPE $28.38M $32.13M $32.12M $18.17M $23.30M
Net PPE $18.99M $19.79M $20.91M $8.62M $15.19M
Total Non-Current Assets $109.81M $68.45M $20.99M $33.50M $22.02M
Other Current Assets $17.18M $13.75M $19.54M $12.59M $9.99M
Restricted Cash $201,000.00 $210,000.00 $1.80M $1.47M $3.35M
Inventory $5.40M $8.09M $28.68M $27.53M $15.79M
-Accounts Receivable $106.82M $79.07M $56.95M $50.60M $29.41M
Receivables $106.82M $79.07M $56.95M $50.60M $29.41M
-Short Term Investments $185.01M $216.14M $278.34M $119.54M $3.21M
-Cash and Cash Equivalents $89.74M $104.71M $110.64M $304.77M $504.39M
Cash and Cash Equivalents & Short-Term Investments $274.75M $320.85M $388.99M $424.31M $507.60M
Total Current Assets $404.35M $421.97M $495.97M $516.50M $566.14M
Total Assets $514.16M $490.42M $516.96M $550.00M $588.15M
Payables $24.79M $26.23M $39.42M $22.06M $34.86M
-Accounts Payable $15.83M $11.64M $20.89M $14.36M $27.81M
Total Equity -$119.15M -$475.93M -$455.53M -$294.60M -$106.99M
Stockholders' Equity -$119.15M -$475.93M -$455.53M -$294.60M -$106.99M
Capital Stock $2.13M $2.09M $2.06M $1.88M $1.84M
-Common Stock $2.13M $2.09M $2.06M $1.88M $1.84M
-Preferred Stock $0.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $1.38B $1.29B $1.22B $1.16B $1.10B
Retained Earnings -$1.51B -$1.77B -$1.68B -$1.45B -$1.21B
-Accumulated Depreciation -$9.39M -$12.35M -$11.21M -$9.55M -$8.11M
-Long Term Capital Lease Obligation $10.01M $10.05M $11.24M $5.80M $5.96M
-Long Term Debt $427.23M $795.92M $811.27M $733.28M $585.46M
Long Term Debt and Capital Lease Obligation $437.25M $805.97M $822.50M $739.08M $591.42M
Current Accrued Expenses $39.96M $17.96M $21.33M $43.41M $38.99M
Short-Term Debt and Capital Lease Obligation $1.63M $2.77M $2.65M $2.37M $1.82M
-Current Capital Lease Obligation $1.63M $2.77M $2.65M $2.37M $1.82M
Current Provisions $26.63M $32.12M $26.51M $14.33M $5.96M
Other Current Liabilities $52.20M $32.68M $23.57M – –
Total Non-Current Liabilities $437.25M $805.97M $822.50M $739.08M $591.42M
-Other Payable $8.96M $14.59M $18.52M $7.70M $4.43M
Current Deferred Liabilities – – – $1.22M $1.42M
-Total Tax Payable – – – – $2.62M

Discussion

No comments yet — be the first to weigh in on BCRX.

Leave a comment

Scroll to Top